Purchase Order 75N93023P00357
Award Date 3/1/23
Potential Completion Date 2/29/24
Potential Value $165K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hamilton, MT 59840, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Illumina, Inc., a manufacturer of sequencing and array-based solutions, a firm fixed-price purchase order for the maintenance and service of Illumina equipment, including NextSeq 2000, MiSeq, and iSeq 100 sequencing systems, with a potential value of $208,172.00. The contract has a period of performance from March 1, 2023, to February 28, 2026, and was awarded...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $238,269.44 contract is for Illumina equipment maintenance services in support of the agency's genomic sequencing and analysis research. Illumina is an authorized service provider for the Illumina equipment, which...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc. for approximately $140,000. The contract is for service agreements to provide preventative maintenance, technical support, software and hardware updates for multiple Illumina DNA sequencers located at the NIH Vaccine Research Center in Bethesda, Maryland, over a one year period of performance from...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for an annual service agreement to maintain NIAID's Illumina MiSeq and NextSeq 500 sequencing systems used to support ongoing research on influenza and respiratory diseases. The contract has a total ceiling value...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq and NextSeq maintenance service agreement. The contract has a ceiling value of $54,252.56 and a performance period ending on March 24, 2030. Illumina is a manufacturer of genetic sequencing systems and related consumables. The award does not utilize any small business set-asides....
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $53,029.50 firm-fixed price purchase order to Illumina, Inc. for a one-year service plan covering preventative maintenance, full parts and labor coverage, reagent replacement, remote technical support, and software/hardware updates for the agency's Illumina NextSeq 2000 sequencing equipment at their Laboratory of Viral Diseases. This purchase was made under full and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for MISSEQ, CBOT2 AND HISEQ 4000 BRONZE AND SILVER MAINTENANCE PLANS. The $124,639.96 contract does not have a set-aside designation. Illumina has previously been awarded federal contracts by agencies such as the NIH, CDC, USDA, and VA...